The National Cancer Data Base: Report on kidney cancers

Cancer

Volumn 80, Issue 11, 1997, Pages 2167-2174

  Marshall, Fray F ^a   Stewart, Andrew K ^b   Menck, Herman R ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

Author keywords

Kidney cancer; National Cancer Data Base; Nephrectomy; Renal cell carcinoma; Surgery; Survival; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DATA BASE; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEPHRECTOMY; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMERICAN CANCER SOCIETY; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 0030719995     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971201)80:11<2167::AID-CNCR18>3.0.CO;2-X     Document Type: Article

References (25)

1. American Cancer Society. Cancer Facts and Figures - 1997. Atlanta: American Cancer Society, 1997.
2. McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni JF Jr. A population-based case control study of renal cell carcinoma. J Natl Cancer Inst 1984;72:275-84.
3. Mandel JS, McLaughlin JK, Schlehofer B, Mellemgaard A, Helmert U, Lindblad P, et al. International renal-cell cancer study. IV. Occupation. Int J Cancer 1995;61:601-5.
4. Laniell JM, Salazar FG, Hsia YE. von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 1989;68:1-29.
5. Jessup JM, Steele GD, Winchester DP. Introduction. In: Steele GD, Jessup JM, Winchester DP, Menck HR, Murphy GP, editors. National Cancer Data Base Annual Review of Patient Care, 1995. Atlanta: American Cancer Society, 1995:1-11.
6. SPSS for Windows. Advanced statistics. Release 6.1. Chicago: SPSS Inc., 1994.
7. Marubini E, Valsecchi MG. Analyzing survival data from clinical trials and observational studies. New York: John Wiley & Sons, 1995.
8. Shambaugh E, Young JL Jr., Zipin C, Lum D, Akers C, Weiss MA. Statistics and epidemiology for cancer registrars. Book 7. Bethesda: National Institutes for Health, 1995.
9. Lee ET. Statistical methods for survival data analysis. Belmont, CA: Wandsworth, Inc., 1980.
10. Percey C, Van Holten V, Muir C, editors. International classification of disease for oncology. (2nd edition.) Geneva: World Health Organization, 1990.
11. American Joint Committee on Cancer. Manual for staging of cancer. (4th edition.) Beahrs OH, Henson DE, Hutter RVP, Kennedy BK, editors. Philadelphia: J.B. Lippincott Company, 1992.
12. Commission on Cancer, American College of Surgeons. Standards of the Commission on Cancer. Volume I: Cancer programs standards. Chicago: Commission on Cancer, 1996.
13. Polascik TJ, Pound CR, Meng MV, Partin AW, Marshall, FF. Partial nephrectomy: technique, complications, and pathological findings. J Urol 1995;154:1312-8.
14. Motzer RJ, Bander NH, Nanus DM. Review article: renal-cell carcinoma. N Engl J Med 1996;335:865-75.
15. Smith SJ, Bosniak MA, Megibow AJ, Hulnickl DH, Horii SC, Raghvendra BN. Renal cell carcinoma: earlier discovery and increased detection. Radiology 1989;170:699-703.
16. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
17. Latif F, Tory K, Gnarre J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
18. Sweatt WH, Simons JW. Gene therapy for genitourinary cancer. In: Raghaven R, Scher HI, Leibel SA, Lange PH, editors. Principles and practice of genitourinary oncology. Philadelphia: Lippincott-Raven, 1997:121-30.
19. Störkel S, Eble J, Adlakha K, Amin M, Blute ML, Bostwick DG, et al. Classification of renal cell carcinoma: Workgroup No. 1. Cancer 1997;80:987-9.
20. Isaacs WB, Brooks JD, Bova GS, Marshall FF. Tumor suppressor gene allelic loss in human renal cancers. J Urol 1993;150:1278-83.
21. Pound CR, Partin AW, Epstein JI, Simons JW, Marshall FF. Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma. Urology 1993; 42:243-8.
22. Yagoda A, Abi-Rached B, Petrylak D. Chemotherapy for advanced renal-cell carcinoma: 1983-1993. Semin Oncol 1995;22:42-60.
23. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987;316:889-97.
24. Jaffee EM, Dranoff G, Cohen L, Hands KM, Clift S, Marshall FF, et al. High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res 1993; 53:2221-6.
25. American Joint Committee on Cancer. AJCC cancer staging manual. (5th edition.) Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. Philadelphia: J.B. Lippincott Company, 1997.